Keyphrases
Botulinum Neurotoxin (BoNT)
100%
Trigeminal Ganglion
100%
Inflammatory Mediators
100%
Organ Culture
100%
Culture Studies
100%
OnabotulinumtoxinA
85%
Inducible Nitric Oxide Synthase
57%
SNAP-25
57%
Interleukin-1β
42%
Chronic Migraine
42%
U0126
42%
Sodium Chloride
28%
Inflammation
14%
Immunohistochemistry
14%
Novel Therapeutics
14%
Pain Reduction
14%
Corticosteroids
14%
Inflammatory Markers
14%
Immunoreactivity
14%
MEK1
14%
Enhanced Expression
14%
Mitogen
14%
Long-term Adverse Effects
14%
Culture Method
14%
Transmitter
14%
Degree of Inflammation
14%
Primary Antibody
14%
Differential Distribution
14%
Docking Protein
14%
Co-incubation
14%
Synaptic Vesicle Docking
14%
Sensory Mechanisms
14%
Fresh Specimen
14%
Toxin Receptor
14%
Medicine and Dentistry
Botulinum Toxin A
100%
Ganglion
100%
Organ Culture
100%
Inflammatory Mediator
100%
Synaptosomal Associated Protein 25
57%
Calcitonin Gene Related Peptide
42%
Interleukin 1
42%
U0126
42%
Transformed Migraine
42%
Side Effect
14%
Symptom
14%
Receptor
14%
Immunohistochemistry
14%
Immunoreactivity
14%
Incubation
14%
Mitogenic Agent
14%
Synaptic Vesicle
14%
Docking Protein
14%
Botulinum Toxin
14%
Pharmacology, Toxicology and Pharmaceutical Science
Botulinum Toxin A
100%
Synaptosomal Associated Protein 25
100%
Calcitonin Gene Related Peptide
75%
Transformed Migraine
75%
1,4 Diamino 1,4 Bis(2 Aminophenylthio) 2,3 Dicyanobutadiene
75%
Interleukin 1
75%
Inflammation
50%
Side Effect
25%
Receptor
25%
Symptom
25%
Mitogenic Agent
25%
Docking Protein
25%
Botulinum Toxin
25%
Neuroscience
Botulinum Toxin
100%
Trigeminal Ganglion
100%
Synaptosomal Associated Protein 25
57%
Migraine
42%
U0126
42%
Interleukin 1
42%
Sodium Chloride
28%
Eicosanoid Receptor
14%
Immunohistochemistry
14%
Synaptic Vesicle
14%
Signal Recognition Particle Receptor
14%